Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Bordeaux | OTHER |
| Institut National de la Santé Et de la Recherche Médicale, France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
The study aims at evaluating the phenomena of immune system aging in patients with Systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease characterized by a breakdown of tolerance against nuclear antigens. Thanks to improvements during the last decades in diagnosis, therapeutics and medical care, the lifespan of SLE patients has remarkably increased. However, standardized mortality ratio are still high in this population, with an increased mortality and morbidity associated with cardiovascular events and infectious events. Interestingly, these conditions are more commonly found during old age in the general population, raising the question of the presence of an acceleration of the aging process in SLE patients.
It has been demonstrated that the aging of the immune system, i.e. immunosenescence, is a key player in the development of many age-related diseases. The acceleration of immunosenescence, as it is observed during chronic viral infections for example, could favor the premature occurrence of clinical manifestations of accelerated aging. The exact contribution of such phenomenon in the context of SLE has, so far, never been explored.
Here, the investigators propose to perform a comprehensive study of the phenomena of immune system aging in patients with SLE in comparison to age-matched healthy controls.
The study will recruit 50 SLE patients followed in Bordeaux University Hospital. Among classical disease activity information, blood samples will be collected at study visit to extensively evaluate immune system aging. Fundamental research will be realized on patients' samples. Patients will be included within their usual follow-up. No extra visit will be needed, and blood samples will be drawn at the same time as those drawn for clinical purposes.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Systemic Lupus Erythematosus | Experimental | Diagnosis of systemic lupus erythematosus according to American College of Rheumatology (ACR) or SLICC criteria |
|
| Controls | Other | Healthy controls |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood sample | Biological | 48 ml whole blood for Peripheral blood mononuclear cell (PBMC) and serum isolation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Absolute numbers of naïve T lymphocytes | At baseline (Day 0) |
| Measure | Description | Time Frame |
|---|---|---|
| Absolute numbers of terminally differentiated T lymphocytes | At baseline (Day 0) | |
| Percentages of terminally differentiated T lymphocytes among total lymphocytes | At baseline (Day 0) | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Noemie GENSOUS, MD | Contact | (0)5 56 79 58 28 | +33 | noemie.gensous@chu-bordeaux.fr |
| Name | Affiliation | Role |
|---|---|---|
| Noemie GENSOUS, MD | University Hospital, Bordeaux | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Bordeaux - Médecine Interne et Immunologie Clinique | Recruiting | Bordeaux | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008180 | Lupus Erythematosus, Systemic |
| ID | Term |
|---|---|
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| blood sample | Biological | blood for Peripheral blood mononuclear cell (PBMC) and serum isolation |
|
| Percentages of senescent lymphocytes among total lymphocytes |
| At baseline (Day 0) |
| Telomere length in sorted CD4+ and CD8+ T lymphocytes subsets (naïve and memory) | At baseline (Day 0) |
| Frequency and phenotype of ELA-specific CD8+ T-cells after 10 days of in vitro priming | At baseline (Day 0) |
| Number of naïve T lymphocytes newly produced by thymus evaluated by T-cell receptor excision circles (TRECs) measurement | At baseline (Day 0) |
| Concentrations of senescence-associated secretory phenotype (SASP) markers in patients sera | At baseline (Day 0) |
| Presence or absence of anti-type I interferons autoantibodies in patients sera | At baseline (Day 0) |
| Measurement of disease activity according to Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) | At baseline (Day 0) |
| Measurement of disease activity according to British Lupus Assessment Group Index 2004 (BILAG-2004) | At baseline (Day 0) |
| Quantification of organ damage according to SLICC/ACR Damage Index | At baseline (Day 0) |
| Levels of anti-double stranded DNA in patients sera | At baseline (Day 0) |
| Levels of complement components C3 and C4 in patients sera | At baseline (Day 0) |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |